Health

Prostate Cancer: Before You Agree to a Biopsy, Know Which Tests Should Come First

Prostate cancer is one of the most common cancers affecting men, yet many men still avoid talking about it, delay testing, or assume that urinary problems are simply part of

Prostate Cancer: Before You Agree to a Biopsy, Know Which Tests Should Come First
  • PublishedNovember 15, 2026

Prostate cancer is one of the most common cancers affecting men, yet many men still avoid talking about it, delay testing, or assume that urinary problems are simply part of getting older. Others receive an elevated PSA result and immediately fear the worst. But an important part of prostate cancer detection is understanding what an abnormal test actually means—and knowing what should happen before moving to a biopsy.

Imagine going to your doctor for a routine checkup, receiving a call a few days later, and hearing that your PSA level is elevated. Suddenly, you are wondering whether you have cancer, whether you need a biopsy, and what happens next.

It is an unsettling moment, but it is important to understand one thing: an elevated PSA does not automatically mean prostate cancer, and it does not automatically mean a biopsy is necessary.

There are several steps doctors can take to better understand the results, evaluate risk, and determine whether a biopsy is appropriate.

Knowing the difference between these tests could help men make more informed decisions, avoid unnecessary procedures, and identify potentially serious cancer when it matters most.

ADVERTISEMENT

What Is Prostate Cancer?

The prostate is a small gland located below the bladder and in front of the rectum. It surrounds part of the urethra, the tube that carries urine out of the body, and produces fluid that helps nourish and transport sperm.

Prostate cancer develops when cells in the prostate begin growing abnormally.

Some prostate cancers grow very slowly and may never cause serious health problems. Others can grow more aggressively and spread beyond the prostate.

That distinction is important. Finding prostate cancer does not automatically mean immediate surgery, radiation, or other aggressive treatment is necessary. The type, grade, stage, and overall risk of the cancer help determine what should happen next.

The First Test: The PSA Blood Test

The PSA test is generally the first screening test used to evaluate prostate cancer risk.

PSA stands for prostate-specific antigen, a protein produced by cells in the prostate. A simple blood test measures how much of this protein is circulating in the bloodstream.

A higher PSA level can be associated with prostate cancer, but it can also be caused by noncancerous conditions.

ADVERTISEMENT

There is no single PSA number that definitively confirms or rules out prostate cancer.

Some doctors use 4.0 ng/mL as a general reference point, but age, prostate size, medical history, previous PSA results, and other risk factors matter. Cancer can also be present when PSA is below 4.0.

The PSA test is valuable because it can identify a reason to investigate further, not because it provides a diagnosis by itself.

What Can Raise Your PSA Besides Cancer?

Several conditions and activities can temporarily or persistently increase PSA levels:

  • Enlarged prostate (BPH): A common noncancerous enlargement that can increase PSA.
  • Prostatitis: Inflammation or infection of the prostate.
  • Urinary infections: Infections involving the urinary tract or prostate can affect PSA readings.
  • Ejaculation: Can temporarily increase PSA.
  • Cycling: Pressure around the prostate may temporarily influence results in some men.
  • Recent urinary procedures: Certain procedures involving the prostate or urinary tract can affect PSA.

Some medications, including finasteride and dutasteride, can lower PSA levels. This is important because a lower reading while taking these medications may need special interpretation.

Before testing, tell your doctor about your medications, supplements, recent infections, and any urinary procedures. Your doctor may also recommend avoiding ejaculation and vigorous cycling for approximately 48 hours before the blood draw.

If Your PSA Is Elevated, What Should Come Next?

This is where men should become active participants in their healthcare.

An elevated PSA does not necessarily mean the next step is a biopsy. In many cases, doctors can perform additional testing to better understand the result.

ADVERTISEMENT

A common evaluation pathway looks like this:

1. Repeat the PSA blood test.

If the PSA is newly elevated, guidelines from the American Urological Association recommend repeating the test before moving to additional biomarkers, imaging, or biopsy. PSA can fluctuate, and confirming the result can prevent unnecessary investigations.

The National Cancer Institute notes that a repeat test may be recommended in approximately six to eight weeks, depending on the circumstances.

2. Consider a digital rectal examination.

A doctor may perform a digital rectal exam, commonly called a DRE, to feel the prostate through the rectal wall. The doctor is checking for unusual firmness, enlargement, or lumps.

The examination is brief, but it provides information that a blood test cannot.

3. Consider additional blood or urine tests.

If PSA remains elevated, additional tests may help estimate the likelihood of clinically significant prostate cancer. Examples include the free PSA test, Prostate Health Index (PHI), and 4Kscore.

4. Consider a prostate MRI.

A multiparametric MRI can provide detailed images of the prostate and help identify areas that may be suspicious for cancer.

5. Decide whether a biopsy is necessary.

The decision should consider the full picture, including PSA results, MRI findings, prostate size, examination findings, family history, and other risk factors.

These steps do not have to occur in precisely the same order for every patient. A suspicious examination, very high PSA, or other concerning findings may justify a more direct evaluation.

The Prostate MRI: An Important Step Before Biopsy

One of the most important developments in prostate cancer evaluation is the increasing use of multiparametric MRI before an initial biopsy.

An MRI does not diagnose prostate cancer by itself. Instead, it helps doctors see the prostate in greater detail and identify areas that may need further investigation.

It can help answer important questions:

  • Is there an area that looks suspicious?
  • Where is that area located?
  • How large is the prostate?
  • Is there a target that should be sampled during a biopsy?
  • Does the overall picture suggest that a biopsy is necessary?

MRI findings are commonly reported using a system called PI-RADS, which assigns a score from 1 to 5 based on how suspicious an area appears.

A higher score generally indicates greater suspicion, but the score is not a cancer diagnosis.

A negative MRI can sometimes support monitoring rather than immediate biopsy when the overall risk is low. However, a negative MRI does not completely rule out significant cancer. If PSA density, family history, examination findings, or other factors remain concerning, a biopsy may still be appropriate.

The European Association of Urology recommends MRI before biopsy in men with suspected localized prostate cancer. The decision should still be individualized with a urologist.

When Should a Man Have a Prostate Biopsy?

A prostate biopsy is generally considered when the combined findings suggest a meaningful risk of clinically significant cancer.

This may include:

  • PSA levels that remain elevated or continue to rise.
  • A suspicious finding during a digital rectal examination.
  • A suspicious lesion on prostate MRI.
  • Concerning PSA density, which compares PSA with prostate size.
  • Additional blood or urine test results suggesting increased cancer risk.
  • Strong family history or inherited genetic risk combined with concerning test results.
  • Persistent suspicion despite previous negative testing.

A biopsy should not be based on one number alone whenever additional risk assessment is appropriate.

There are situations where a doctor may recommend proceeding directly to biopsy, particularly when findings are strongly suspicious. However, patients should feel comfortable asking why the procedure is recommended and whether additional testing could help guide the decision.

What Actually Happens During a Prostate Biopsy?

A prostate biopsy is the procedure used to confirm whether cancer is present.

During the procedure, a doctor removes small samples of tissue from the prostate using a thin needle. A pathologist examines those samples under a microscope.

There are two commonly used approaches:

Transrectal biopsy: The needle passes through the wall of the rectum into the prostate, usually with ultrasound guidance.

Transperineal biopsy: The needle passes through the skin between the scrotum and anus, also known as the perineum.

MRI findings may be combined with ultrasound images to guide the needle toward suspicious areas. This is often called MRI-ultrasound fusion biopsy.

The doctor may also take systematic samples from other areas of the prostate because cancer can exist outside the suspicious area seen on MRI.

Is a Prostate Biopsy Painful?

Many men worry about discomfort, embarrassment, and possible complications.

The procedure is generally performed with local anesthesia, sometimes with sedation or other pain management depending on the technique and medical setting.

Some men experience pressure, brief discomfort, or soreness afterward.

Temporary blood in the urine, semen, or stool can occur. Infection is another possible complication, and although uncommon, it can become serious. Temporary difficulty urinating can also occur.

Transperineal biopsy is increasingly used because it generally carries a lower risk of infection than the transrectal approach.

Men should ask their urologist which approach is recommended and why.

Fever, chills, worsening pain, or difficulty passing urine after a biopsy require prompt medical attention.

What If the Biopsy Finds Cancer?

A positive biopsy does not automatically mean that treatment must begin immediately.

The pathology report provides important information about the type and grade of cancer.

One of the most important measurements is the Gleason score, which is also reported using Grade Groups.

These results help doctors understand how abnormal the cancer cells appear and how likely the cancer may be to grow or spread.

Some men with low-risk prostate cancer may be candidates for active surveillance. This involves regular monitoring with PSA tests, examinations, MRI, and sometimes repeat biopsies.

The purpose is to avoid or delay treatment when the cancer is unlikely to cause harm, while continuing to watch for signs that it is becoming more aggressive.

Other cancers require more active treatment, which may include surgery, radiation, hormone therapy, or other approaches depending on the stage and individual circumstances.

The right treatment is not necessarily the most aggressive treatment. It is the treatment strategy that best fits the cancer and the person.

Signs of Prostate Cancer That Can Be Confusing

Early signs of prostate cancer

One reason prostate cancer can be difficult to recognize is that many symptoms overlap with common, noncancerous prostate and urinary conditions.

In fact, early prostate cancer often causes no symptoms at all.

When symptoms do appear, they can include:

  • Frequent urination, particularly at night.
  • Difficulty starting urination.
  • A weak or interrupted urine stream.
  • Feeling that the bladder has not emptied completely.
  • Blood in the urine or semen.
  • Pain or discomfort in the pelvic area.
  • Erectile difficulties.

But these symptoms do not automatically indicate cancer.

An enlarged prostate can cause frequent nighttime urination and a weak stream. Prostatitis can cause pelvic discomfort, painful urination, and sometimes fever. Urinary infections can cause burning and frequent urination.

The challenge is that symptoms alone cannot reliably distinguish these conditions.

Blood in the urine or semen, persistent urinary changes, and unexplained pelvic discomfort should be evaluated rather than ignored.

Severe back or bone pain, unexplained weight loss, or new weakness or numbness may occur in advanced disease or other serious conditions and require prompt medical evaluation. New leg weakness, numbness around the groin, or loss of bladder or bowel control requires emergency assessment.

Who Should Be Tested Earlier?

Risk is not the same for every man.

Age is an important factor, but family history and inherited genetics can change when screening discussions should begin.

Men who should consider discussing earlier screening include:

  • Black men, who have a higher risk of developing prostate cancer and dying from it.
  • Men whose father or brother had prostate cancer, particularly if diagnosed at a younger age.
  • Men with a known BRCA2 gene mutation or certain other inherited cancer-risk mutations.
  • Men with multiple relatives affected by prostate, breast, ovarian, pancreatic, or related cancers.

Some medical organizations suggest that men at higher risk begin discussing PSA testing around ages 40 to 45, while average-risk men commonly begin the conversation around age 50.

Screening decisions should consider overall health, life expectancy, personal preferences, and the potential benefits and harms of testing. More testing is not always better, particularly when a slow-growing cancer may never affect a person’s health.

10 Questions Every Man Should Ask His Doctor

If you are discussing prostate cancer screening, have received an elevated PSA, or have been told you may need a biopsy, consider asking:

  1. What is my PSA level, and how does it compare with my previous results?
  2. Could my elevated PSA be related to an enlarged prostate, infection, inflammation, or another condition?
  3. Should we repeat the PSA before moving to additional testing?
  4. Would a free PSA, PHI, or 4Kscore test help clarify my risk?
  5. Should I have a multiparametric prostate MRI before considering a biopsy?
  6. What did my digital rectal examination reveal?
  7. What specific findings make you recommend a biopsy?
  8. Would a transperineal biopsy be appropriate, and what are the benefits and risks compared with a transrectal biopsy?
  9. If the biopsy is negative, what happens next, and how will we continue monitoring my risk?
  10. If cancer is found, could active surveillance be an option, or would treatment be recommended?

These questions can help turn a stressful appointment into a more informed conversation.

The Bottom Line: Get Tested, Ask Questions, and Understand the Next Step

Prostate cancer awareness is not simply about reminding men to get a PSA test. It is about helping them understand what happens after that test.

An elevated PSA deserves attention, but it is not a cancer diagnosis. Repeating the test, considering additional blood or urine markers, performing a prostate MRI, and evaluating personal risk can help doctors determine whether a biopsy is truly necessary.

A biopsy remains the way to confirm prostate cancer, but men should understand why it is being recommended, what type of procedure will be used, and what the possible results could mean.

Do not ignore persistent urinary changes. Do not assume every prostate problem is cancer. And do not let embarrassment prevent you from having an important conversation with your doctor.

The most powerful step a man can take is not simply getting tested. It is becoming informed enough to understand the results and make the next decision with confidence.


Medical Disclaimer

This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Prostate cancer screening and biopsy decisions should be individualized with a qualified healthcare professional, preferably a urologist when further evaluation is needed. PSA results alone cannot diagnose or rule out prostate cancer. Never delay medical evaluation because of information in this article.

Written By
RAVOKE News desk